莎普愛思(603168.SH):擬再次掛牌轉讓強身藥業100%股權 轉讓底價調至9771.41萬元
格隆匯 1 月 27日丨莎普愛思(603168.SH)公佈,2021年1月7日,公司召開總經理辦公會議,會議審議通過了《關於強身藥業股權掛牌轉讓價格調整相關事項》,同意將強身藥業100%股權掛牌轉讓底價調整為11725.69萬元。2020年1月11日,上海聯合產權交易所啟動下一輪掛牌轉讓程序,掛牌公吿期為2020年1月12日至2021年1月25日,掛牌底價為11,725.69萬元。截止2021年1月25日,強身藥業100%股權公開掛牌信息披露期滿,本輪掛牌轉讓未徵集到意向受讓方。
2021年1月26日,公司召開總經理辦公會議,會議審議通過了《關於強身藥業股權掛牌轉讓價格調整相關事項》,同意將強身藥業100%股權掛牌轉讓底價調整為9771.41萬元。2021年1月27日,上海聯合產權交易所啟動下一輪掛牌轉讓程序,掛牌公吿期為2021年1月28日至2021年2月9日,掛牌底價為9771.41萬元。相關掛牌信息詳見上海聯合產權交易所網,網站地址:https://www.suaee.com/。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.